There are more than 8 million undiagnosed diabetics in the US (26.5M total) and 79 million pre-diabetics.

As most adults visit a primary eye care practice for reading glasses starting at the age of 40, primary eye care is a perfect initial venue for screening for diabetes and monitoring disease progression. Michigan Aerospace is helping OcuSciences build products that can rapidly and non-invasively detect and monitor retinal metabolic dysfunction due to a variety of diseases, including diabetes and macular degeneration, at an earlier stage than currently possible and before irreversible cell damage occurs.

The initial focus is on early detection of diabetes and pre-diabetes and the monitoring of disease progression due to retinal cell damage.

Learn more at www.ocusciences.com


Your browser is out of date. It has security vulnerabilities and may not display all features on this site and other sites.

Please update your browser using one of modern browsers (Google Chrome, Opera, Firefox, IE 10).